Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kairos Pharma (KAPA) Invested Capital (2024 - 2025)

Kairos Pharma (KAPA) has disclosed Invested Capital for 2 consecutive years, with $6.0 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Invested Capital rose 325.96% year-over-year to $6.0 million, compared with a TTM value of $6.0 million through Jun 2025, up 325.96%, and an annual FY2024 reading of $4.8 million, changed N/A over the prior year.
  • Invested Capital was $6.0 million for Q2 2025 at Kairos Pharma, down from $7.1 million in the prior quarter.
  • Across five years, Invested Capital topped out at $7.1 million in Q1 2025 and bottomed at -$2.7 million in Q2 2024.